Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant Der P 2 expressed in Pichia Pastoris as a “natural-like” allergen for immunotherapy and diagnostic purposes

Recombinant Der P 2 expressed in Pichia Pastoris as a “natural-like” allergen for immunotherapy and diagnostic purposes

US Patent 9868770 · Granted Jan 16, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids2021
IL-10 as a predictive biomarker of responsiveness to house dust mite allergen im2021
Markers of immune response2021
Markers of immune response2021
Sialylated fetuin-A as a marker of immunotherapy efficacy2021
Sialylated fetuin-A as a marker of immunotherapy efficacy2021
Sialylated fetuin-A as a marker of immunotherapy efficacy2021
Compositions for antigen-specific induction of tolerance2020
Recombinant or transgenic factor VII composition, each factor VII molecule havin2019
Recombinant or transgenic factor VII composition, each factor VII molecule havin2019
Methods for identifying dendritic cell subsets, for determining if a patient is 2019
Methods for identifying dendritic cell subsets, for determining if a patient is 2019